Innovega Launches Equity Crowdfunding Campaign with Crowdfunder

BELLEVUE, Wash., Sept. 19, 2019 /PRNewswire/ — Innovega Inc., a company engaged in developing stylish, lightweight, wearable display technology with a panoramic field of view for virtual and augmented reality, launched an equity crowdfunding round with Crowdfunder, a leader in funding high-growth ventures. Funds will be earmarked to move Innovega’s eMacula  toward commercial launch.

Innovega’s eMacula is a wearable display system that includes patented disposable soft contact lenses (“smart lenses”) and a range of display eyewear (“smart glasses”). This combination system meets wearers’ parallel demands for lightweight, stylish eyewear and access to high-quality media with a high-resolution, panoramic field of view. eMacula provides a synthesis of features that is unavailable in other AR/VR products — which are typically encumbered by heavy, obtrusive headsets or eyewear with a narrow display field.

With a network of more than 130,000 entrepreneurs and investors, Crowdfunder is an equity crowdfunding leader for sourcing and funding high-growth ventures. Crowdfunder provides access to a global network of accredited investors who participate in funding startups.

Innovega’s business model allows established contact lens manufacturers to bring the eMacula system’s smart lenses to market, and allows multiple manufacturing and distribution partners to commercialize its display eyewear, configured for many applications or use cases. Its patented portfolio of Enhanced Retina Technologies covers the system of contact lenses and smart glasses, including key sub-systems such as eye tracking, and is protected by twenty-six filed patent applications and thirteen granted U.S. patents.

To learn more about Innovega and the eMacula system, and the opportunity for equity investment during the current limited-time funding round, please visit https://www.crowdfunder.com/innovega.

About Innovega

Innovega’s eMacula combination of stylish glasses and smart contact lenses provides the user with a discreet, high performance entertainment and information experience that goes beyond any available system. The company was co-founded by prominent inventor and optometrist Jerome A. Legerton and Stephen Willey, former CEO of augmented reality pioneer MicroVision. Innovega has been funded by grants from the National Science Foundation, Defense Advanced Research Projects Agency, the National Institutes of Health National Eye Institute and from private investment.

Media Inquiries:  Stephen Willey  |  223268@email4pr.com  |  Cell: 425-516-8175

View original content:http://www.prnewswire.com/news-releases/innovega-launches-equity-crowdfunding-campaign-with-crowdfunder-300921668.html

SOURCE Innovega Inc.

Staff

Recent Posts

MindHYVE.ai™ and KPSIAJ Sign Strategic MOU to Advance AI-Driven Innovation in Education and Healthcare Across Karachi

KARACHI, Pakistan, Dec. 22, 2025 /PRNewswire/ -- MindHYVE.ai, Inc., and Khoja (Pirhai) Shia Isna Asheri Jamaat…

58 minutes ago

Castle Connolly Names Dr. Meegan Gruber, MD, PhD a 2026 Exceptional Woman in Medicine; Recognition to Be Featured in New York Magazine

Board-certified plastic surgeon and surgeon-scientist honored for clinical excellence, leadership, and commitment to patient education. …

59 minutes ago

Planning Time Off in 2026: Dr. Meegan Gruber, MD, PhD Releases a Recovery-Logistics Guide for Busy Professionals Considering Plastic Surgery

New "Recovery Logistics" checklist helps patients coordinate work, childcare, travel, and follow-up support-before they choose…

59 minutes ago

How to Choose a Plastic Surgeon in 2026: Dr. Meegan Gruber, MD, PhD Releases a Tampa Bay Patient Safety Checklist

Board-certified plastic surgeon shares a practical, question-based guide to help patients verify credentials, facility standards,…

59 minutes ago

Facelift + Eyelid Surgery in Tampa: Gruber Plastic Surgery Shares 2025 Planning Insights on Natural Results and Popular Procedure Pairings

ASPS trend reporting highlights facelift combined with eyelid surgery as a leading 2025 combination; national…

59 minutes ago

CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD

SAN DIEGO, CA / ACCESS Newswire / December 22, 2025 / CV Sciences, Inc. (OTCQB:CVSI)…

4 hours ago